deterioration of ligaments, cartilage, collagen and tendons.
Our traditional source of minerals has been from fresh fruit, vegetables and some dairy products. Today we have to look at other sources to get sufficient minerals for a healthy diet. Some of the reasons for this are:
1) Loss of minerals in the soil
2) Modern food processing methods
3) Popularity of 'Junk' foods
An increasing number of people are turning to mineral supplements for their source of minerals.
The information contained in this article is for educational purposes only and is not intended to medically diagnose, treat or cure any disease. Consult a health care practitioner before beginning any health care program.
About the Author
Emily Clark is editor at Arthritis Health News, where arthritis sufferers can find the most up-to-date advice and information to assist in improving their quality of life.
Written By: Emily Clark

Medication fears lead to worse side effects - Vancouver Sun
NEW YORK - It may not be surprising, but a new study offers some proof that patients who are worried about their medications are more likely to have side effects from them. The study involved patients with a particular kind of arthritis. While more ...
Roche, Biogen Suspend Arthritis Drug Program After Patient Deaths - Daily Finance
An independent safety monitoring board recommended the pharmaceutical firms halt the program after concluding that the safety risks outweighed the benefits observed in some patients. Specifically, the board detected "serious and opportunistic ...
UPDATE 2-Roche suspends arthritis treatment after deaths - Reuters
ZURICH, March 8 (Reuters) - Swiss drugmaker Roche Holding AG ( ROG.VX ) and U.S.-listed Biogen Idec ( BIIB.O ) are suspending rheumatoid arthritis and lupus treatment ocrelizumab after it caused deaths, casting doubt over the drug's future. Roche and ...
UPDATE 4-Roche, Biogen suspends arthritis drug after deaths - Reuters
ZURICH, March 8 (Reuters) - Swiss drugmaker Roche Holding AG ( ROG.VX ) and U.S. biotechnology company Biogen Idec ( BIIB.O ) are suspending experimental rheumatoid arthritis and lupus treatment ocrelizumab after deaths following its use, casting ...
Roche, Biogen Idec Suspend Tests for Arthritis Drug (Update3) - BusinessWeek
March 8 (Bloomberg) -- Roche Holding AG and Biogen Idec Inc. are suspending development of the ocrelizumab treatment for use in arthritis after an independent monitoring board said safety risks outweigh benefits observed in these patients. The ...
Roche, Biogen suffer setback with rheumatoid arthritis drug - Marketwatch
ZURICH (MarketWatch) -- Roche Holding AG (ROG.VX) and Biogen Idec Inc (NASDAQ:BIIB) said Monday they suspended a rheumatoid arthritis program using drug candidate ocrelizumab because of safety concerns, further cutting the experimental drug's market ...
Major Pharmaceutical Company Stops Arthritis Study After Deaths - FOX News
Swiss pharmaceutical company Roche Group said Monday it has suspended a late-stage trial for a new rheumatoid arthritis and lupus drug after several patients died from infections. Roche said the drug, ocrelizumab, was developed together with Biogen ...